Insights
Tomorrow's Global Business
Life Sciences & Antitrust: 3 Cases to Watch in 2018
January 26, 2018
By Paul Hastings Professional
Life Sciences & Antitrust: 3 Cases to Watch in 2018
The intersection of complex drug competition frameworks and antitrust laws continues to grow, with increased collaboration between the U.S. FDA and FTC on the horizon. Hear from our lawyers on three cases to watch in 2018.